Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
作者： T Brazelton
DOI: 10.1016/S0952-7915(96)80090-2
关键词:
摘要: … seen in patients treated with tacrolimus. In no clinical or experimental studies has inhibition of … the efficacy of sirolimus for prevention of intimal thickening in transplanted vascular grafts. …
elsevier.com
sci-hub.se 参考文章(67)
H. W. SOLLINGER, Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. ,vol. 60, pp. 225- 232 ,(1995) , 10.1097/00007890-199508000-00003
Paul W. Hager, Frank R. Collart, Eliezer Huberman, Beverly S. Mitchell, Recombinant human inosine monophosphate dehydrogenase type I and type II proteins: Purification and characterization of inhibitor binding Biochemical Pharmacology. ,vol. 49, pp. 1323- 1329 ,(1995) , 10.1016/0006-2952(95)00026-V
T Nakagoori, T Kenmochi, T Uematsu, T Ochiai, M Nagata, T Asano, K Nakajima, S Hori, T Goto, T Suzuki, Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplantation proceedings. ,vol. 19, pp. 1284- 1286 ,(1987)
H Hatanaka, H Imanaka, M Nishiyama, T Kino, M Okuhara, M Kohsaka, H Aoki, T Goto, Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplantation proceedings. ,vol. 19, pp. 4- 8 ,(1987)
R. Kurrle, F. R. Seiler, New Immunosuppressive Drugs Cancer in Organ Transplant Recipients. pp. 169- 176 ,(1991) , 10.1007/978-3-642-75991-8_17
E W Gelfand, K Takase, P Papst, N Terada, A C Nairn, Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes. Journal of Immunology. ,vol. 155, pp. 3418- 3426 ,(1995)
Y Vanrenterghem, H Ekberg, J Grinyo, G Tufveson, C Groth, D Cantarovich, L Mjornstedt, S Sadek, R Pichlmayr, F Moreso, G Gannedahl, P Lang, Adam Tegzess, J Rodicio, van Willem Son, A Morgan, A Tarantino, J Peeters, M Campise, J Lodge, K Hutchinson, J Erhard, K Wagner, L Hooftman, S Carl, G Ligtenberg, G Thiel, R Luck, M Wiesel, M Zeiler, Hh Neumayer, Sa Sadek, Jp Soulillou, K Rigg, B Bourgeon, P Fauchald, Hauser, C Brattstrom, R Hene, M Behrend, D Albrechtsen, N Persson, J Morales, PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION The Lancet. ,vol. 345, pp. 1321- 1325 ,(1995)
Lynette D. Fairbanks, Margarita Bofill, Katarzyna Ruckemann, H. Anne Simmonds, Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. Journal of Biological Chemistry. ,vol. 270, pp. 29682- 29689 ,(1995) , 10.1074/JBC.270.50.29682
Goran B. Klintmalm, Ronald W. Busuttil, Transplantation of the Liver ,(1996)
R. B. Pearson, P. B. Dennis, J. W. Han, N. A. Williamson, S. C. Kozma, R. E. Wettenhall, G. Thomas, The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. The EMBO Journal. ,vol. 14, pp. 5279- 5287 ,(1995) , 10.1002/J.1460-2075.1995.TB00212.X